Gland Pharma

Market Cap: Small Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE068V01023
NSEID: GLAND
BSEID: 543245
View on NSE | View on BSE

INR

2,512.50

-4.5 (-0.18%)

BSENSE

Jul 31, 02:33 PM

BSE+NSE Vol: 2.21 lacs

{
  "main_header": {
    "sid": 1003443,
    "name": "Gland Pharma",
    "stock_name": "Gland Pharma",
    "full_name": "Gland Pharma Ltd",
    "name_url": "stocks-analysis/gland-pharma",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "2,512.50",
    "chg": -4.5,
    "chgp": "-0.18%",
    "dir": -1,
    "prev_price": "2,517.00",
    "mcapval": "41,446.12 Cr",
    "mcap": "Small Cap",
    "scripcode": 543245,
    "symbol": "GLAND",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE068V01023",
    "curr_date": "Jul 31, 02:33 PM",
    "curr_time": "14:50 PM",
    "last_traded_at": "Jul 31, 02:33 PM IST",
    "bse_nse_vol": "2.21 lacs",
    "exc_status": "Active",
    "traded_date": "Jul 31, 2026",
    "traded_date_str": "2026 07 31",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/gland-pharma-1003443-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Broad-Based Technical Strength Lifts Gland Pharma Ltd to 52-Week High of Rs 2585.55",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-ltd-hits-new-52-week-high-at-rs258555-4128412",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/GlandPharmaLtd_priceRelatedfactors_4128412.png",
        "date": "2026-07-30 10:08:19",
        "description": "Surging to a new 52-week high of Rs 2,585.55 on 30 Jul 2026, Gland Pharma Ltd has demonstrated robust price momentum, outpacing its sector and the broader market with a 24.7% gain over the past year against the Sensex’s decline of 4.6%. This milestone reflects a confluence of technical signals aligning favourably across multiple timeframes, underscoring the stock’s sustained upward trajectory."
      },
      {
        "title": "Gland Pharma Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gland-pharma-ltd-is-rated-buy-4121074",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/GlandPharmaLtd_mojoScore_4121074.png",
        "date": "2026-07-26 10:10:29",
        "description": "Gland Pharma Ltd is rated Buy by MarketsMOJO, with this rating last updated on 29 May 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 26 July 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Gland Pharma Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gland-pharma-ltd-is-rated-buy-4103623",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/GlandPharmaLtd_mojoScore_4103623.png",
        "date": "2026-07-15 10:11:02",
        "description": "Gland Pharma Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 29 May 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 15 July 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Gland Pharma Ltd to 52-Week High of Rs 2574",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-ltd-hits-new-52-week-high-at-rs2574-4093213",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/GlandPharmaLtd_priceRelatedfactors_4093213.png",
        "date": "2026-07-08 09:49:07",
        "description": "With a decisive breakthrough to Rs 2,574 on 8 Jul 2026, Gland Pharma Ltd has reached a fresh 52-week high, extending its impressive 34.09% rally over the past year. This milestone comes amid a backdrop of strong technical momentum and sustained outperformance relative to the broader market."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Gland Pharma Ltd to 52-Week High of Rs 2535",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-ltd-hits-new-52-week-high-at-rs2535-4092098",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/GlandPharmaLtd_priceRelatedfactors_4092098.png",
        "date": "2026-07-07 10:07:53",
        "description": "Surging to a fresh 52-week high of Rs 2,535 on 7 Jul 2026, Gland Pharma Ltd has demonstrated robust price momentum, outpacing its sector and the broader market. This milestone caps a year-long rally that has delivered a 34.43% return, significantly outperforming the Sensex’s decline of 5.99% over the same period."
      },
      {
        "title": "Gland Pharma Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gland-pharma-ltd-is-rated-buy-4088302",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/GlandPharmaLtd_mojoScore_4088302.png",
        "date": "2026-07-04 10:10:33",
        "description": "Gland Pharma Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 29 May 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 04 July 2026, providing investors with the most recent and relevant data to assess the company’s prospects."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Gland Pharma Ltd to 52-Week High of Rs 2438.5",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-ltd-hits-new-52-week-high-at-rs24385-4078494",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/GlandPharmaLtd_priceRelatedfactors_4078494.png",
        "date": "2026-06-30 09:56:47",
        "description": "Surging to a fresh 52-week high of Rs 2438.5 on 30 Jun 2026, Gland Pharma Ltd has demonstrated robust price momentum, outperforming its sector by 2.61% today and extending gains over the past two sessions to 5.29%. This milestone caps a year-long rally that has delivered a 33.11% return, significantly outpacing the Sensex’s decline of 8.50% over the same period."
      },
      {
        "title": "Gland Pharma Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gland-pharma-ltd-is-rated-buy-4068881",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/GlandPharmaLtd_mojoScore_4068881.png",
        "date": "2026-06-23 10:10:54",
        "description": "Gland Pharma Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 29 May 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock’s current position as of 23 June 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Gland Pharma Gains 1.00%: Technical Upgrade and Earnings Drive Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-gains-100-technical-upgrade-and-earnings-drive-momentum-4051887",
        "imagepath": "",
        "date": "2026-06-13 16:00:06",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>1 June:</strong> MarketsMOJO upgrades Gland Pharma to Buy on strong technical and financial performance</p>\n                    <p><strong>1 June:</strong> Technical momentum shifts signal bullish outlook amid volatility</p>\n                    <p><strong>5 June:</strong> Stock closes the week at Rs.2,272.15, up 1.00% for the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\">\n                        <div class=\"stat-label\">Week Open</div>\n                        <div class=\"stat-value\">Rs.2,249.75</div>\n                    </div>\n                    <div class=\"stat-item\">\n                        <div class=\"stat-la..."
      }
    ],
    "total": 405,
    "sid": "1003443",
    "stock_news_url": "https://www.marketsmojo.com/news/gland-pharma-1003443"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "10 Aug 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Gland Pharma Ltd has declared <strong>2000%</strong> dividend, ex-date: 11 Aug 26",
          "dt": "2026-08-11",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Broad-Based Technical Strength Lifts Gland Pharma Ltd to 52-Week High of Rs 2585.55

2026-07-30 10:08:19

Surging to a new 52-week high of Rs 2,585.55 on 30 Jul 2026, Gland Pharma Ltd has demonstrated robust price momentum, outpacing its sector and the broader market with a 24.7% gain over the past year against the Sensex’s decline of 4.6%. This milestone reflects a confluence of technical signals aligning favourably across multiple timeframes, underscoring the stock’s sustained upward trajectory.

Read full news article

Gland Pharma Ltd is Rated Buy

2026-07-26 10:10:29

Gland Pharma Ltd is rated Buy by MarketsMOJO, with this rating last updated on 29 May 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 26 July 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Gland Pharma Ltd is Rated Buy

2026-07-15 10:11:02

Gland Pharma Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 29 May 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 15 July 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Broad-Based Technical Strength Lifts Gland Pharma Ltd to 52-Week High of Rs 2574

2026-07-08 09:49:07

With a decisive breakthrough to Rs 2,574 on 8 Jul 2026, Gland Pharma Ltd has reached a fresh 52-week high, extending its impressive 34.09% rally over the past year. This milestone comes amid a backdrop of strong technical momentum and sustained outperformance relative to the broader market.

Read full news article

Broad-Based Technical Strength Lifts Gland Pharma Ltd to 52-Week High of Rs 2535

2026-07-07 10:07:53

Surging to a fresh 52-week high of Rs 2,535 on 7 Jul 2026, Gland Pharma Ltd has demonstrated robust price momentum, outpacing its sector and the broader market. This milestone caps a year-long rally that has delivered a 34.43% return, significantly outperforming the Sensex’s decline of 5.99% over the same period.

Read full news article

Gland Pharma Ltd is Rated Buy

2026-07-04 10:10:33

Gland Pharma Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 29 May 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 04 July 2026, providing investors with the most recent and relevant data to assess the company’s prospects.

Read full news article

Broad-Based Technical Strength Lifts Gland Pharma Ltd to 52-Week High of Rs 2438.5

2026-06-30 09:56:47

Surging to a fresh 52-week high of Rs 2438.5 on 30 Jun 2026, Gland Pharma Ltd has demonstrated robust price momentum, outperforming its sector by 2.61% today and extending gains over the past two sessions to 5.29%. This milestone caps a year-long rally that has delivered a 33.11% return, significantly outpacing the Sensex’s decline of 8.50% over the same period.

Read full news article

Gland Pharma Ltd is Rated Buy

2026-06-23 10:10:54

Gland Pharma Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 29 May 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock’s current position as of 23 June 2026, providing investors with the latest insights into the company’s performance and outlook.